Evidence map›Paper›PMID 38383596›Full record

ArticleNature communications2024

A convergent evolutionary pathway attenuating cellulose production drives enhanced virulence of some bacteria.

Nguyen Thi Khanh Nhu, M Arifur Rahman, Kelvin G K Goh, Seung Jae Kim, Minh-Duy Phan, Kate M Peters, Laura Alvarez-Fraga, Steven J Hancock, Chitra Ravi, Timothy J Kidd and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
6.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. NeuO-mediated O-acetylation of uropathogenicJournal of bacteriology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Modified TnApplied and environmental microbiology · 2024
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Nguyen Thi Khanh Nhu *Institute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0002-0158-850X
M Arifur Rahman *Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, Australia.
Kelvin G K Goh *School of Pharmacy and Medical Sciences, Griffith University, Southport, QLD, Australia.ORCID 0000-0001-8347-2043
Seung Jae Kim *School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0003-0268-6029
Minh-Duy PhanInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0002-3426-1044
Kate M PetersInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD, Australia.
Laura Alvarez-FragaSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
Steven J HancockSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
Chitra RaviInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD, Australia.
Timothy J KiddSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
Matthew J SullivanSchool of Pharmacy and Medical Sciences, Griffith University, Southport, QLD, Australia.ORCID 0000-0003-2276-3132
Katharine M IrvineAustralian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0002-6716-1605
Scott A BeatsonSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0002-1806-3283
Matthew J SweetInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0002-0406-8139
Adam D IrwinAustralian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0001-8974-6789
Jana VukovicSchool of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia. j.vukovic@uq.edu.au.ORCID 0000-0002-3739-1688
Glen C UlettSchool of Pharmacy and Medical Sciences, Griffith University, Southport, QLD, Australia. g.ulett@griffith.edu.au.ORCID 0000-0002-9638-8091
Sumaira Z HasnainAustralian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, Australia. sumaira.hasnain@mater.uq.edu.au.ORCID 0000-0001-8577-8628
Mark A SchembriInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD, Australia. m.schembri@uq.edu.au.ORCID 0000-0003-4863-9260
The University of Queensland · AUGriffith University · AUQueen's University Belfast · GBUniversity of East Anglia · GB

Funding

Medical Research Council
6 · The paper itself

Abstract

Bacteria adapt to selective pressure in their immediate environment in multiple ways. One mechanism involves the acquisition of independent mutations that disable or modify a key pathway, providing a signature of adaptation via convergent evolution. Extra-intestinal pathogenic Escherichia coli (ExPEC) belonging to sequence type 95 (ST95) represent a global clone frequently associated with severe human infections including acute pyelonephritis, sepsis, and neonatal meningitis. Here, we analysed a publicly available dataset of 613 ST95 genomes and identified a series of loss-of-function mutations that disrupt cellulose production or its modification in 55.3% of strains. We show the inability to produce cellulose significantly enhances ST95 invasive infection in a rat model of neonatal meningitis, leading to the disruption of intestinal barrier integrity in newborn pups and enhanced dissemination to the liver, spleen and brain. Consistent with these observations, disruption of cellulose production in ST95 augmented innate immune signalling and tissue neutrophil infiltration in a mouse model of urinary tract infection. Mutations that disrupt cellulose production were also identified in other virulent ExPEC STs, Shigella and Salmonella, suggesting a correlative association with many Enterobacteriaceae that cause severe human infection. Together, our findings provide an explanation for the emergence of hypervirulent Enterobacteriaceae clones.

Indexed as

Escherichia coli InfectionsEscherichia coli ProteinsMeningitisAnimalsEscherichia coliHumansMicePhylogenyRatsVirulenceVirulence FactorsEscherichia coli ProteinsVirulence Factors

Identifiers

PMID38383596
PMCPMC10881479
OpenAlexW4391997388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.